Amer Karam
Overview
Explore the profile of Amer Karam including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
33
Citations
740
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Lang S, Lee B, Karam A
Gynecol Oncol Rep
. 2024 Jun;
53:101367.
PMID: 38841265
•Deloyers procedure is an alternative to ileorectal anastomosis.•Deloyers procedure can be performed after a prior partial colectomy.•Use of this procedure may help achieve complete gross resection during cytoreductive surgery.
2.
Somasegar S, Anastasio M, Karam A, Rossi E, Obermair A
Am Soc Clin Oncol Educ Book
. 2024 May;
44(3):e438550.
PMID: 38815208
Cancer outcomes are largely measured in terms of disease-free survival or overall survival, which is highly dependent on timely diagnosis and access to treatment methods available within the country's existing...
3.
Somasegar S, Reddy R, Chow S, Dorigo O, Renz M, Karam A
Gynecol Oncol
. 2024 Feb;
184:190-197.
PMID: 38330833
Objective: To characterize trends in ovarian, fallopian tube, and primary peritoneal cancer incidence and incidence-based mortality based on histology and site of origin. Methods: We obtained age-adjusted incidence and incidence-based...
4.
Hui C, Mendoza M, von Eyben R, Dorigo O, Litkouhi B, Renz M, et al.
Gynecol Oncol
. 2023 Sep;
177:150-156.
PMID: 37696217
Objective: The PORTEC-2 update suggested that substantial lymphovascular space invasion (LVSI) and abnormal p53 expression (p53abnl) predict for poorer outcomes and that these patients should be treated with external beam...
5.
Hui C, Mendoza M, Snyder J, Dorigo O, Litkouhi B, Renz M, et al.
Gynecol Oncol
. 2023 May;
174:42-48.
PMID: 37149904
Objectives: Emerging data suggests that abnormal (nuclear) β-catenin expression in some settings is associated with poorer outcomes. Our study aimed to verify the significance of abnormal β-catenin expression in early-stage...
6.
Armstrong D, Alvarez R, Backes F, Bakkum-Gamez J, Barroilhet L, Behbakht K, et al.
J Natl Compr Canc Netw
. 2022 Sep;
20(9):972-980.
PMID: 36075393
Epithelial ovarian cancer is the leading cause of death from gynecologic cancer in the United States, with less than half of patients living >5 years following diagnosis. The NCCN Guidelines...
7.
Reddy R, Moon A, Chow S, Heilbroner L, Howitt B, Diver E, et al.
Gynecol Oncol Rep
. 2022 Aug;
43:101054.
PMID: 35958955
Background: Technetium Tc 99m tilmanocept is a synthetic radiotracer specifically designed for sentinel lymph node (SLN) mapping that has been FDA-approved in breast cancer, melanoma, and head and neck cancer....
8.
Chow S, Karam A
Curr Opin Obstet Gynecol
. 2021 Dec;
34(1):15-19.
PMID: 34967810
Purpose Of Review: To provide an overview of the current knowledge and recent advances of sentinel lymph node (SLN) assessment in uterine, cervical, vulvar, and ovarian cancers. Recent Findings: In...
9.
Devereaux K, Weiel J, Pors J, Steiner D, Ho C, Charu V, et al.
Mod Pathol
. 2021 Nov;
35(5):688-696.
PMID: 34743187
The comprehensive genomic analysis of endometrial carcinoma (EC) by The Cancer Genome Atlas (TCGA) led to the discovery of four distinct and prognostically significant molecular subgroups. Molecular classification has the...
10.
Pan M, Ganjoo K, Karam A
Perm J
. 2021 May;
25.
PMID: 33970096
Patients with metastatic uterine leiomyosarcoma (uLMS) have poor prognosis due to limited treatment options, especially when disease progresses on doxorubicin and gemcitabine-docetaxel regimens. Here we report a patient whose metastatic...